<DOC>
	<DOCNO>NCT00988130</DOCNO>
	<brief_summary>RATIONALE : High-intensity focus ultrasound focal ablation use high-energy sound wave kill tumor cell . PURPOSE : This phase II trial study side effect high-intensity focus ultrasound focal ablation see well work treat patient progressive prostate cancer .</brief_summary>
	<brief_title>High-Intensity Focused Ultrasound Focal Ablation Treating Patients With Progressive Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To evaluate side effect high-intensity focus ultrasound ( HIFU ) ablation men non-metastatic progressive prostate cancer . - To evaluate quality life patient treat regimen . Secondary - To determine success index lesion ablation HIFU 6 month treatment demonstrate absence cancer treat ablated area transrectal ultrasound biopsy . - To evaluate prostate-specific antigen kinetics index lesion ablation patient treat regimen . - To evaluate proportion men require androgen blockade 12 month follow-up . OUTLINE : Patients undergo focal ablation high-intensity focus ultrasound ( HIFU ) ablation day 1 . Treatment may repeat 6 month patient progressive disease . Blood sample prostate biopsy collect periodically analysis . Patients complete questionnaire ( IPSS , IPSS-QoL , ICS , IIEF-5 , FACT-P ) baseline periodically study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm prostate cancer transrectal transperineal template prostate biopsy Stage ≤ T3bN0M0 Gleason grade ≤ 8 Serum PSA ≤ 20 ng/mL Bone scan crosssectional imagingnegative metastatic nodal ( outside prostate ) disease No metastatic disease and/or nodal spread CT scan MRI Index lesion secondary lesion volume ≥ 0.5 cc MRI No prostatic calcification cyst ( transrectal ultrasound ) would interfere effective delivery therapy PATIENT CHARACTERISTICS : Able tolerate transrectal ultrasound Not allergic latex Fit major surgery assess consultant anaesthetist Able MRI scan ( i.e. , none follow condition : severe claustrophobia , permanent cardiac pacemaker , metallic implant , etc . ) PRIOR CONCURRENT THERAPY : No prior radiotherapy No androgen suppression and/or hormone treatment within past 12 month No prior significant rectal surgery prevent insertion transrectal highintensity focus ultrasound ( HIFU ) probe ( decide type surgery individual case ) No prior transurethral resection prostate ( equivalent procedure ) within past 2 year No prior HIFU , cryosurgery , thermal , microwave therapy prostate</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>sexual dysfunction</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
</DOC>